For: | Abdalla MMI. Serum resistin and the risk for hepatocellular carcinoma in diabetic patients. World J Gastroenterol 2023; 29(27): 4271-4288 [PMID: 37545641 DOI: 10.3748/wjg.v29.i27.4271] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i27/4271.htm |
Number | Citing Articles |
1 |
Mohammed Baqur S. Al-Shuhaib, Sarfaraz Alam, Salman Ali Khan, Hayder O. Hashim, Daniel H. Obayes, Jafar M. B. Al-Shuhaib.
Masoprocol: a promising candidate for targeting insulin resistance by inhibiting resistin with optimal druglikeness Potentials: an
in silico
approach
. Journal of Biomolecular Structure and Dynamics 2024; 42(19): 10044 doi: 10.1080/07391102.2023.2254842
|
2 |
S. Melini, C. Pirozzi, A. Lama, F. Comella, N. Opallo, F. Del Piano, E. Di Napoli, M. P. Mollica, O. Paciello, M. C. Ferrante, G. Mattace Raso, R. Meli. Co‐Micronized Palmitoylethanolamide and Rutin Associated With Hydroxytyrosol Recover Diabesity‐Induced Hepatic Dysfunction in Mice: In Vitro Insights Into the Synergistic Effect. Phytotherapy Research 2024; doi: 10.1002/ptr.8361
|
3 |
Noor Hameed Hanoush, Rashied Mohammed Rashied, Abdul Rahman Mohammed Geeran. The role of leptin, resistin, and irisin levels as prognostic indicators of lung cancer in Iraqi patients. Egyptian Journal of Basic and Applied Sciences 2024; 11(1): 496 doi: 10.1080/2314808X.2024.2362056
|